- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06360926
Improvement Image Quality for SuperSonic® MACH Ultrasound System (MACH IQ)
April 8, 2024 updated by: SuperSonic Imagine
The aim of this Study is to collect radiologist feedback to support the further development and improvement of the imaging modes implemented on the embedded software in the SuperSonic® Ultrasound System (including the probe).
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Subject is ≥ 18 years old and is able to understand and sign the informed consent form.
- Subject is a minor < 18 years old and the legal representative has signed the informed consent form.
- Subject is scheduled for at least one or more routine ultrasounds.
- Subject is affiliated to National Social Insurance or a Health Insurance Regimen.
Exclusion Criteria:
- Subject is unable or unwilling to adhere to Study procedures.
- Subject or his/her legal representative if a minor is unable to express or understand informed consent.
- Subject is under legal protection
- Subject is deprived of liberty by judicial or administrative decision
- Subject undergoes psychiatric treatment under constraint
- Subject is admitted to a health or social establishment for purposes other than research
- Subject has latex allergy.
- Subject has an open wound, cut, and/or a rash which would preclude an ultrasound imaging procedure
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: SuperSonic® Ultrasound System equipped with new software iterations used with a new probe
|
SuperSonic® Ultrasound System equipped with new software iterations used with a new probe and CE marked probes.
The new software and probe are the new study investigational device not CE marked
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Qualitative assessment of image quality
Time Frame: During ultrasound procedure
|
Following the two ultrasound procedures, the radiologist will rate the image quality produced by the Study Device, compared to that produced by the SOC ultrasound.
A score from 1 to 5 (1: Not acceptable; 2: Acceptable; 3: Fair; 4: Good; 5: Excellent) for each of the characteristics of the image: General Aesthetics; Spatial Resolution; Contrast Resolution; Temporal Resolution; Penetration and Sensitivity
|
During ultrasound procedure
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2024
Primary Completion (Estimated)
May 1, 2025
Study Completion (Estimated)
May 1, 2025
Study Registration Dates
First Submitted
March 19, 2024
First Submitted That Met QC Criteria
April 8, 2024
First Posted (Actual)
April 11, 2024
Study Record Updates
Last Update Posted (Actual)
April 11, 2024
Last Update Submitted That Met QC Criteria
April 8, 2024
Last Verified
April 1, 2024
More Information
Terms related to this study
Other Study ID Numbers
- 2024-A00526-41
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Diagnosis
-
Beytepe Murat Erdi Eker State HospitalCompletedAnterior Segment Ischemia (Diagnosis)
-
Identifai GeneticsRecruitingGenetics | Prenatal DiagnosisUnited States
-
Danderyd HospitalRecruiting
-
Stanford UniversityBeth Israel Deaconess Medical Center; University of MinnesotaCompleted
-
University Hospital, LimogesUniversity Hospital, BordeauxNot yet recruiting
-
Aisap LTDCompletedDiagnosisUnited States, Israel
-
University of Southern DenmarkCompletedSymptoms on Admission | Presumptive Diagnosis on Admission | Final DiagnosisDenmark
-
Ankara Education and Research HospitalCompletedDiagnosis | Axilla; BreastTurkey
-
Seoul National University HospitalBayerCompleted
-
Hillel Yaffe Medical CenterCompletedPrenatal DiagnosisIsrael
Clinical Trials on SuperSonic® Ultrasound System
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
University of WashingtonNational Cancer Institute (NCI)UnknownThyroid NoduleUnited States
-
Dr. Linda McLeanOttawa Hospital Research Institute; The Ottawa HospitalEnrolling by invitation
-
Institut National de la Santé Et de la Recherche...CompletedMalignant Breast TumoursFrance
-
Rennes University HospitalCompletedHepatic TransplantationFrance
-
University of MagdeburgCompleted
-
National Taiwan University HospitalRecruitingRadiofrequency AblationTaiwan
-
Seoul National University HospitalCompletedBreast CancerKorea, Republic of
-
Erasmus Medical CenterReCor Medical, Inc.Not yet recruitingHypertension | Kidney Transplantation
-
University Hospital, GenevaTerminatedAcute Heart FailureSwitzerland